Diabetes
News
FDA to revise safety evaluation of type 2 diabetes drugs
The draft guidance will replace the requirement that manufacturers conduct cardiovascular outcomes trials to rule out unacceptable cardiovascular...
Latest News
Risk factors for death from COVID-19 identified in Wuhan patients
The odds of dying in the hospital increased with age, higher SOFA score, and D-dimer level exceeding 1 mcg/L.
Latest News
CMS to test model limiting out-of-pocket costs for insulin
The Part D Senior Savings Model would lower out-of-pocket costs to a maximum of a $35 copay for a 30-day supply throughout the plan year.
From the Journals
Study: Glycemic control improved in fasting diabetic Muslims
This research has implications beyond the observant Muslim community, notes Dr. Jonathan G. Gabison.
From the Journals
Rotavirus vaccination is not a risk factor for type 1 diabetes
The findings should provide reassurance that rotavirus vaccination can be safely administered to infants.
From the Journals
Biomarker pattern flags risk for microalbuminuria in diabetes patients
Earlier identification of at-risk individuals could be useful in guiding targeted preventive therapy.
From the Journals
RYGB tops sleeve gastrectomy in long-term outcomes for diabetes
New findings could help patients, clinicians, and policy makers in making informed decisions about which procedure is best suited to patients’...
From the Journals
Putting diabetes tools ‘in the pocket’ improves HbA1c control
Patients with greater clinical need benefited most from having mobile access to a portal housing diabetes-management tools.
From the Journals
Frequent tooth brushing may reduce diabetes risk
Presence of periodontal disease and an increased number of missing teeth may be augmenting factors.
News
Arsenic levels in infant rice cereal are down
Seventy-six percent of samples of infant rice cereal tested in 2018 had levels of arsenic at or below 100 parts per billion.
From the Journals
What are the most prescribed medications for type 2 diabetes?
Empagliflozin and dulaglutide were the most-prescribed drugs in their respective classes for treating type 2 diabetes over 5 years.